Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SKARVAN, K.
Right arrow Articles by PRIEBE, H.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SKARVAN, K.
Right arrow Articles by PRIEBE, H.-J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1988, Vol. 60, No. 6 660-670
© 1988 The Board of Management and Trustees of the British Journal of Anaesthesia

research-article

CARDIOVASCULAR EFFECTS OF DILTIAZEM IN THE DOG

K. SKARVAN and H.-J. PRIEBE

KARL SKARVAN, M.D.; HANS-JOACHIM PRIEBE, M.D.; Department of Anaesthesia, University of Basel/Kantonsspital, CH-4031 Basel, Switzerland.

The effects of two bolus injections (0.2 mg kg–1) and two infusion rates (0.2 mg min–1 and 0.4 mg min–1) ofdiltiazem on global and regional left (LV) and right ventricular (RV) performance (ultrasonic dimension technique), on coronary (electromagnetic flow meters) and systemic haemodynamics, and on electrophysiology (PR, QRS, QTC intervals) were studied in eight open-chest dogs anaesthetized with droperidol and fentanyl. The two bolus injections of diltiazem resulted in plasma concentrations of 688 ± 115 and 650 ± 85 ng ml–1 (means ± SE), respectively, and caused substantial decreases in systemic and coronary vascular resistances, and in aortic pressure, and increases in LV segment shortening, stroke volume and aortic flow. Electro -physiological variables were little affected. At the low infusion rate (plasma concentration 140 ± 23 ng ml–1) coronary and systemic vaso-dilatation occurred, but global and regional RV and LV performance were little affected. PR interval increased by 15%. At the higher infusion rate (plasma concentration 282 ± 33 ng ml–1) coronary and systemic vasodilatation were maintained. Aortic pressure decreased slightly. Whereas LV end-diastolic and end-systolic dimensions remained unchanged, they increased in the RV. In addition, the PR interval increased by 35%, and three animals developed atrio-ventricular block type I. The data indicate that diltiazem is a potent coronary and systemic vasodilator with little effect on global RV and L V performance. However, at a higher infusion rate RV dimensions clearly tend to increase, and conduction abnormalities develop.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.